{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:13:08Z","timestamp":1780704788801,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["LY23H160012"],"award-info":[{"award-number":["LY23H160012"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373176"],"award-info":[{"award-number":["82373176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35239-5","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:22:18Z","timestamp":1768638138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploration of potential biomarkers in salivary duct carcinoma based on bioinformatics analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"35239_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cncy.22288","volume":"128","author":"M Nakaguro","year":"2020","unstructured":"Nakaguro, M. et al. Salivary duct carcinoma: updates in Histology, Cytology, molecular Biology, and treatment. Cancer Cytopathol. 128, 693\u2013703 (2020).","journal-title":"Cancer Cytopathol."},{"key":"35239_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF00301495","volume":"192","author":"O Kleinsasser","year":"1968","unstructured":"Kleinsasser, O., Klein, H. J. & H\u00fcbner, G. [Salivary duct Carcinoma. A group of salivary gland tumors analogous to mammary duct Carcinoma]. Arch. Klin. Exp. Ohren Nasen Kehlkopfheilkd. 192, 100\u2013105 (1968).","journal-title":"Arch. Klin. Exp. Ohren Nasen Kehlkopfheilkd"},{"key":"35239_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.adaj.2018.03.029","volume":"149","author":"P Reichart","year":"2018","unstructured":"Reichart, P., Sciubba, J. J. & Philipsen, H. P. Splitters or lumpers: the 2017 who classification of head and neck tumours. J. Am. Dent. Assoc. 149, 567\u2013571 (2018).","journal-title":"J. Am. Dent. Assoc."},{"key":"35239_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12105-022-01435-8","volume":"16","author":"O Mete","year":"2022","unstructured":"Mete, O. & Wenig, B. M. Update from the 5Th edition of the world health organization classification of head and neck tumors: overview of the 2022 who classification of head and neck neuroendocrine neoplasms. Head Neck Pathol. 16, 123\u2013142 (2022).","journal-title":"Head Neck Pathol."},{"key":"35239_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.oraloncology.2017.05.005","volume":"71","author":"V Osborn","year":"2017","unstructured":"Osborn, V. et al. Characterization, treatment and outcomes of salivary ductal carcinoma using the National cancer database. Oral Oncol. 71, 41\u201346 (2017).","journal-title":"Oral Oncol."},{"key":"35239_CR6","doi-asserted-by":"publisher","first-page":"693394","DOI":"10.3389\/fonc.2021.693394","volume":"11","author":"K Egebjerg","year":"2021","unstructured":"Egebjerg, K., Harwood, C. D., Woller, N. C., Kristensen, C. A. & Mau-Sorensen, M. Her2 positivity in histological subtypes of salivary gland carcinoma: A systematic review and Meta-Analysis. Front. Oncol. 11, 693394 (2021).","journal-title":"Front. Oncol."},{"key":"35239_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jamaoto.2015.3930","volume":"142","author":"MR Gilbert","year":"2016","unstructured":"Gilbert, M. R. et al. A 20-Year review of 75 cases of salivary duct carcinoma. Jama Otolaryngol-Head Neck Surg. 142, 489\u2013495 (2016).","journal-title":"Jama Otolaryngol-Head Neck Surg."},{"key":"35239_CR8","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1245\/s10434-015-5082-2","volume":"23","author":"K Otsuka","year":"2016","unstructured":"Otsuka, K. et al. Clinical outcomes and prognostic factors for salivary duct carcinoma: A Multi-Institutional analysis of 141 patients. Ann. Surg. Oncol. 23, 2038\u20132045 (2016).","journal-title":"Ann. Surg. Oncol."},{"key":"35239_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.oraloncology.2017.02.018","volume":"68","author":"G Keller","year":"2017","unstructured":"Keller, G. et al. New concepts of personalized therapy in salivary gland carcinomas. Oral Oncol. 68, 103\u2013113 (2017).","journal-title":"Oral Oncol."},{"key":"35239_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hed.23350","volume":"36","author":"V Jayaprakash","year":"2014","unstructured":"Jayaprakash, V. et al. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the Surveillance, Epidemiology, and end results database. Head Neck. 36, 694\u2013701 (2014).","journal-title":"Head Neck"},{"key":"35239_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.oraloncology.2017.09.008","volume":"74","author":"NC Schmitt","year":"2017","unstructured":"Schmitt, N. C., Kang, H. & Sharma, A. Salivary duct carcinoma: an aggressive salivary gland malignancy with opportunities for targeted therapy. Oral Oncol. 74, 40\u201348 (2017).","journal-title":"Oral Oncol."},{"key":"35239_CR12","doi-asserted-by":"publisher","first-page":"e1234","DOI":"10.1002\/lio2.1234","volume":"9","author":"EJ Han","year":"2024","unstructured":"Han, E. J. et al. A 22-Year single institution review of 119 cases of salivary duct carcinoma. Laryngoscope Investig Otolaryngol. 9, e1234 (2024).","journal-title":"Laryngoscope Investig Otolaryngol."},{"key":"35239_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12920-015-0144-7","volume":"8","author":"Y Qi","year":"2015","unstructured":"Qi, Y. et al. Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome Snp chip. Bmc Med. Genomics. 8, 69 (2015).","journal-title":"Bmc Med. Genomics"},{"key":"35239_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13000-023-01311-1","volume":"18","author":"X Li","year":"2023","unstructured":"Li, X. et al. Exome sequencing analysis of gastric primary myeloid sarcoma with monocytic differentiation with altered immunophenotype after chemotherapy: case report. Diagn. Pathol. 18, 35 (2023).","journal-title":"Diagn. Pathol."},{"key":"35239_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41598-023-47668-7","volume":"14","author":"R Zhang","year":"2024","unstructured":"Zhang, R. et al. Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis. Sci. Rep. 14, 37 (2024).","journal-title":"Sci. Rep."},{"key":"35239_CR16","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.7150\/thno.42986","volume":"10","author":"M Alame","year":"2020","unstructured":"Alame, M. et al. The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities. Theranostics 10, 4383\u20134394 (2020).","journal-title":"Theranostics"},{"key":"35239_CR17","doi-asserted-by":"crossref","unstructured":"Liu, Z. et al. Identification of hub genes and key pathways associated with two subtypes of diffuse large B-Cell lymphoma based on gene expression profiling via integrated bioinformatics. Biomed. Res. Int. 3574534 (2018).","DOI":"10.1155\/2018\/3574534"},{"key":"35239_CR18","doi-asserted-by":"publisher","first-page":"22036","DOI":"10.1038\/s41598-021-01508-8","volume":"11","author":"J Chinnappan","year":"2021","unstructured":"Chinnappan, J., Ramu, A., S, A. K. & V, V. R. & Integrative bioinformatics approaches to therapeutic gene target selection in various cancers for nitroglycerin. Sci. Rep. 11, 22036 (2021).","journal-title":"Sci. Rep."},{"key":"35239_CR19","doi-asserted-by":"publisher","first-page":"bbab108","DOI":"10.1093\/bib\/bbab108","volume":"22","author":"A Jia","year":"2021","unstructured":"Jia, A., Xu, L. & Wang, Y. Venn diagrams in bioinformatics. Brief. Bioinform. 22, bbab108 (2021).","journal-title":"Brief. Bioinform"},{"issue":"Suppl 4","key":"35239_CR20","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. Cytohubba: identifying hub objects and Sub-Networks from complex interactome. Bmc Syst. Biol. 8 (Suppl 4), S11 (2014).","journal-title":"Bmc Syst. Biol."},{"key":"35239_CR21","first-page":"1133","volume":"18","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. Cystic and solitary nodular pulmonary metastases in a patient with Low-Grade endometrial stromal sarcoma: A case report and literature review. Oncol. Lett. 18, 1133\u20131144 (2019).","journal-title":"Oncol. Lett."},{"key":"35239_CR22","first-page":"e74907","volume":"16","author":"AM Attaelmanan","year":"2024","unstructured":"Attaelmanan, A. M. et al. A comprehensive Pan-Cancer analysis reveals Grb7 as a potential diagnostic and prognostic biomarker. Cureus 16, e74907 (2024).","journal-title":"Cureus"},{"key":"35239_CR23","first-page":"3069","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo, M. et al. Dsigdb: drug signatures database for gene set analysis. Bioinf. (Oxford England). 31, 3069\u20133071 (2015).","journal-title":"Bioinf. (Oxford England)"},{"key":"35239_CR24","doi-asserted-by":"publisher","first-page":"189015","DOI":"10.1016\/j.bbcan.2023.189015","volume":"1878","author":"S Raghuwanshi","year":"2023","unstructured":"Raghuwanshi, S. & Gartel, A. L. Small-Molecule inhibitors targeting Foxm1: current challenges and future perspectives in cancer treatments. Biochim. Biophys. Acta-Rev Cancer. 1878, 189015 (2023).","journal-title":"Biochim. Biophys. Acta-Rev Cancer"},{"key":"35239_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12964-018-0266-6","volume":"16","author":"GB Liao","year":"2018","unstructured":"Liao, G. B. et al. Regulation of the master regulator Foxm1 in cancer. Cell. Commun. Signal. 16, 57 (2018).","journal-title":"Cell. Commun. Signal."},{"key":"35239_CR26","first-page":"247","volume":"12","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Niu, Y. & Huang, C. Role of Foxm1 in the progression and epithelial to mesenchymal transition of Gastrointestinal cancer. Recent. Pat. Anti-Canc Drug Discov. 12, 247\u2013259 (2017).","journal-title":"Recent. Pat. Anti-Canc Drug Discov"},{"key":"35239_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14728222.2020.1727888","volume":"24","author":"S Borhani","year":"2020","unstructured":"Borhani, S. & Gartel, A. L. Foxm1: A potential therapeutic target in human solid cancers. Expert Opin. Ther. Targets. 24, 205\u2013217 (2020).","journal-title":"Expert Opin. Ther. Targets"},{"key":"35239_CR28","first-page":"785","volume":"42","author":"D Yan","year":"2019","unstructured":"Yan, D. et al. Activation of Akt\/Ap1\/Foxm1 signaling confers Sorafenib resistance to liver cancer cells. Oncol. Rep. 42, 785\u2013796 (2019).","journal-title":"Oncol. Rep."},{"key":"35239_CR29","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1038\/s41388-022-02398-4","volume":"41","author":"Y Cheng","year":"2022","unstructured":"Cheng, Y. et al. Foxm1 regulates Glycolysis and energy production in multiple myeloma. Oncogene 41, 3899\u20133911 (2022).","journal-title":"Oncogene"},{"key":"35239_CR30","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1111\/jcmm.17413","volume":"26","author":"Q Yang","year":"2022","unstructured":"Yang, Q., Wu, F., Zhang, Y. & Wang, R. Foxm1 regulates Glycolysis in nasopharyngeal carcinoma cells through Pdk1. J. Cell. Mol. Med. 26, 3783\u20133796 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"35239_CR31","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s10238-023-01037-w","volume":"23","author":"J Zheng","year":"2023","unstructured":"Zheng, J., Bu, X., Wei, X., Ma, X. & Zhao, P. The role of Foxm1 in immune cells. Clin. Exper Med. 23, 1973\u20131979 (2023).","journal-title":"Clin. Exper Med."},{"key":"35239_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/geno.2002.6799","volume":"80","author":"T Maes","year":"2002","unstructured":"Maes, T., Barcel\u00f3, A. & Buesa, C. Neuron navigator: A human gene family with homology to Unc-53, a cell guidance gene from caenorhabditis elegans. Genomics 80, 21\u201330 (2002).","journal-title":"Genomics"},{"key":"35239_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/gcc.22019","volume":"52","author":"E Carlsson","year":"2013","unstructured":"Carlsson, E. et al. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis. Genes Chromosomes Cancer. 52, 191\u2013201 (2013).","journal-title":"Genes Chromosomes Cancer"},{"key":"35239_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00428-017-2172-5","volume":"471","author":"B Davidson","year":"2017","unstructured":"Davidson, B. et al. Neuron Navigator-2 and Cyclin D2 are new candidate prognostic markers in uterine sarcoma. Virchows Arch. 471, 355\u2013362 (2017).","journal-title":"Virchows Arch."},{"key":"35239_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/19336918.2017.1345413","volume":"12","author":"A Pandey","year":"2018","unstructured":"Pandey, A., Yadav, V., Sharma, A., Khurana, J. P. & Pandey, G. K. The Unc-53 gene negatively regulates Rac Gtpases to inhibit Unc-5 activity during distal tip cell migrations in C. Elegans. Celll Adhes. Migr. 12, 195\u2013203 (2018).","journal-title":"Celll Adhes. Migr."},{"key":"35239_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00403-019-01909-w","volume":"311","author":"W Hu","year":"2019","unstructured":"Hu, W. et al. Nav2 facilitates invasion of cutaneous melanoma cells by targeting Snai2 through the Gsk-3\u0392\/\u0392-Catenin pathway. Arch. Dermatol. Res. 311, 399\u2013410 (2019).","journal-title":"Arch. Dermatol. Res."},{"key":"35239_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-015-0237-3","volume":"34","author":"F Tan","year":"2015","unstructured":"Tan, F. et al. Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the Ssh1L\/Cofilin-1 pathway. J. Exp. Clin. Cancer Res. 34, 117 (2015).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"35239_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-022-01050-7","volume":"7","author":"R Wang","year":"2022","unstructured":"Wang, R. et al. Stat3-Nav2 axis as a new therapeutic target for rheumatoid arthritis via activating Ssh1L\/Cofilin-1 signaling pathway. Signal. Transduct. Target. Ther. 7, 209 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"35239_CR39","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s13277-015-3295-4","volume":"36","author":"F V\u00e1zquez-Villa","year":"2015","unstructured":"V\u00e1zquez-Villa, F. et al. Col11a1\/(Pro)Collagen 11a1 expression is a remarkable biomarker of human invasive carcinoma-Associated stromal cells and carcinoma progression. Tumour Biol. 36, 2213\u20132222 (2015).","journal-title":"Tumour Biol."},{"key":"35239_CR40","doi-asserted-by":"publisher","first-page":"e21603","DOI":"10.1096\/fj.202100054RR","volume":"35","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Lai, J., Jiang, H., Ma, C. & Huang, H. Collagen XI alpha 1 Chain, a potential therapeutic target for cancer. Faseb J. 35, e21603 (2021).","journal-title":"Faseb J."},{"key":"35239_CR41","doi-asserted-by":"crossref","unstructured":"Nallanthighal, S., Heiserman, J. P. & Cheon, D. J. Collagen type XI alpha 1 (Col11a1): A novel biomarker and a key player in cancer. Cancers 13, (2021).","DOI":"10.3390\/cancers13050935"},{"key":"35239_CR42","doi-asserted-by":"publisher","first-page":"937125","DOI":"10.3389\/fimmu.2022.937125","volume":"13","author":"W Shi","year":"2022","unstructured":"Shi, W. et al. Col11a1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation. Front. Immunol. 13, 937125 (2022).","journal-title":"Front. Immunol."},{"key":"35239_CR43","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhou, H., Ni, H. & Shen, X. Col11a1-driven epithelial-mesenchymal transition and stemness of pancreatic cancer cells induce cell migration and invasion by modulating the Akt\/Gsk-3\u0392\/snail pathway. Biomolecules. 12, (2022).","DOI":"10.3390\/biom12030391"},{"key":"35239_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2016.09.001","volume":"382","author":"D Jia","year":"2016","unstructured":"Jia, D. et al. A Col11a1-Correlated Pan-Cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. Cancer Lett. 382, 203\u2013214 (2016).","journal-title":"Cancer Lett."},{"key":"35239_CR45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ijc.31353","volume":"143","author":"E Boon","year":"2018","unstructured":"Boon, E. et al. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from the Netherlands. Int. J. Cancer. 143, 758\u2013766 (2018).","journal-title":"Int. J. Cancer"},{"key":"35239_CR46","doi-asserted-by":"publisher","first-page":"59023","DOI":"10.18632\/oncotarget.19812","volume":"8","author":"S Takase","year":"2017","unstructured":"Takase, S. et al. Biomarker Immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification. Oncotarget 8, 59023\u201359035 (2017).","journal-title":"Oncotarget"},{"key":"35239_CR47","doi-asserted-by":"publisher","first-page":"102069","DOI":"10.1016\/j.ctrv.2020.102069","volume":"89","author":"M Uijen","year":"2020","unstructured":"Uijen, M. et al. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review. Cancer Treat. Rev. 89, 102069 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"35239_CR48","doi-asserted-by":"publisher","first-page":"12724","DOI":"10.1038\/s41598-019-49215-9","volume":"9","author":"D Vital","year":"2019","unstructured":"Vital, D., Ikenberg, K., Moch, H., R\u00f6ssle, M. & Huber, G. F. The expression of Pd-L1 in salivary gland carcinomas. Sci. Rep. 9, 12724 (2019).","journal-title":"Sci. Rep."},{"key":"35239_CR49","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/his.13944","volume":"75","author":"B Xu","year":"2019","unstructured":"Xu, B. et al. The immune microenvironment and expression of Pd-L1, Pd-1, Prame and Mhc I in salivary duct carcinoma. Histopathology 75, 672\u2013682 (2019).","journal-title":"Histopathology"},{"key":"35239_CR50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","volume":"33","author":"S Zheng","year":"2023","unstructured":"Zheng, S., Wang, X., Zhao, D., Liu, H. & Hu, Y. Calcium homeostasis and cancer: insights from Endoplasmic Reticulum-Centered organelle communications. Trends Cell. Biol. 33, 312\u2013323 (2023).","journal-title":"Trends Cell. Biol."},{"key":"35239_CR51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.tcb.2018.01.002","volume":"28","author":"C Giorgi","year":"2018","unstructured":"Giorgi, C., Danese, A., Missiroli, S., Patergnani, S. & Pinton, P. Calcium dynamics as a machine for decoding signals. Trends Cell. Biol. 28, 258\u2013273 (2018).","journal-title":"Trends Cell. Biol."},{"key":"35239_CR52","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.molcel.2020.04.017","volume":"78","author":"S Marchi","year":"2020","unstructured":"Marchi, S., Giorgi, C., Galluzzi, L. & Pinton, P. Ca(2+) fluxes and cancer. Mol. Cell. 78, 1055\u20131069 (2020).","journal-title":"Mol. Cell."},{"key":"35239_CR53","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1111\/febs.16133","volume":"288","author":"L Wu","year":"2021","unstructured":"Wu, L., Lian, W. & Zhao, L. Calcium signaling in cancer progression and therapy. Febs J. 288, 6187\u20136205 (2021).","journal-title":"Febs J."},{"key":"35239_CR54","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1158\/0008-5472.CAN-20-2874","volume":"81","author":"AP Kutschat","year":"2021","unstructured":"Kutschat, A. P. et al. Stim1 mediates Calcium-Dependent epigenetic reprogramming in pancreatic cancer. Cancer Res. 81, 2943\u20132955 (2021).","journal-title":"Cancer Res."},{"key":"35239_CR55","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2017.05.045","volume":"153","author":"H Jin","year":"2017","unstructured":"Jin, H. et al. Regulator of calcineurin 1 gene isoform 4, Down-Regulated in hepatocellular Carcinoma, prevents Proliferation, Migration, and invasive activity of cancer cells and metastasis of orthotopic tumors by inhibiting nuclear translocation of Nfat1. Gastroenterology 153, 799\u2013811 (2017).","journal-title":"Gastroenterology"},{"key":"35239_CR56","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.4251\/wjgo.v12.i11.1255","volume":"12","author":"QJ Sheng","year":"2020","unstructured":"Sheng, Q. J. et al. Programmed death 1, ligand 1 and 2 correlated genes and their association with Mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma. World J. Gastrointest. Oncol. 12, 1255\u20131271 (2020).","journal-title":"World J. Gastrointest. Oncol."},{"key":"35239_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2016.11.001","volume":"7","author":"C Cui","year":"2017","unstructured":"Cui, C., Merritt, R., Fu, L. & Pan, Z. Targeting calcium signaling in cancer therapy. Acta Pharm. Sin B. 7, 3\u201317 (2017).","journal-title":"Acta Pharm. Sin B"},{"key":"35239_CR58","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.18632\/oncotarget.22927","volume":"9","author":"T Shimura","year":"2018","unstructured":"Shimura, T. et al. Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas. Oncotarget 9, 1852\u20131867 (2018).","journal-title":"Oncotarget"},{"key":"35239_CR59","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","volume":"22","author":"MG Dalin","year":"2016","unstructured":"Dalin, M. G. et al. Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer. Clin. Cancer Res. 22, 4623\u20134633 (2016).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35239-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35239-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35239-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:03:57Z","timestamp":1770638637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35239-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35239"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35239-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was conducted in accordance with the Declaration of Helsinki for participant\u2019s well-being and safety. Research involving human material, have been performed in accordance with the Declaration of Helsinki. Informed consent was obtained from each patient. Ethical approval was obtained from the Institutional Ethics Review Board (IRB) of the Second Affiliated Hospital of Zhejiang University School of Medicine and the First Affiliated Hospital of Shihezi University School of Medicine (Ethical Approval Number: 2024 0218).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"5525"}}